At a glance
- Originator Jenapharm
- Class Antihyperlipidaemics
- Mechanism of Action Antioxidants; Estrogen receptor agonists; Free radical scavengers
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Menopausal syndrome
Most Recent Events
- 20 May 2003 Preclinical trials in Menopausal syndrome in Germany (unspecified route)